Canature Health Technology (300272.SZ): Overseas revenue generally accounts for about 65% of total annual revenue.

Gelonghui November 15th | Canature Health Technology (300272.SZ) stated during an investor survey on November 15, 2024 that overseas income generally accounts for about 65% of the total annual income. Currently, the company has already reached OEM production agreements or sales framework agreements with several important long-term overseas clients, with the potential to continue leveraging synergies to support the continuous increase in overseas market share.

Gelonghui FinanceNov 15 04:13 ET

There May Be Some Bright Spots In Canature Health Technology's (SZSE:300272) Earnings

Simply Wall StNov 4 02:48 ET

Kaineng Health: Report for the third quarter of 2024

SZSIOct 28 12:00 ET · Announcements

Canature Health Technology (300272.SZ) released performance for the first three quarters, with a net income of 84.165 million yuan, a decrease of 34.92%.

canature health technology (300272.SZ) released the third quarter report of 2024, the company's revenue for the first three quarters was 1...

Zhitong FinanceOct 28 08:41 ET

Canature Health Technology Co., Ltd. (SZSE:300272) Held Back By Insufficient Growth Even After Shares Climb 34%

Simply Wall StOct 25 18:26 ET

A Look At The Fair Value Of Canature Health Technology Co., Ltd. (SZSE:300272)

Simply Wall StOct 4 00:53 ET